The Parade of IPOs Keeps Coming

There sure are a lot of newbies crowding the exchanges.

At least 15 companies have gone public this month, and another three are hoping to price their deals this week.

The last couple of years may have been slow on the IPO front, but the pipeline is starting to seem more like a gusher now.

I recently went over five of last year's debutantes that are reporting quarterly results today. Now let's take a look at some of the companies that have gone public this month.

  • Brightcove (Nasdaq: BCOV  ) is the most recent offering, popping 30% higher Friday after hitting the market at $11. The digital media publishing platform saw its stock tack on another 6% yesterday.
  • HomeStreet (Nasdaq: HMST  ) went public at $44 a week earlier. The Seattle-based financial services company provides banking, investment, and insurance products.
  • GSE Holding (NYSE: GSE  ) is a polymer maker that had to postpone its IPO in December. It was hoping to price its deal between $13 and $15, but had to settle for $9 a stub two months later.
  • Greenway Medical Technologies (NYSE: GWAY  ) provides physicians with electronic health records. It's been one of this month's biggest winners. Greenway went public at $10 during the first week of the month and is now trading 40% higher. Green way, indeed.
  • Ceasars Entertainment (Nasdaq: CZR  ) traded as high as $17 the day it went public, but the casino operator has now fallen back into the preteens.

Shiny and new
February may be the shortest month of the year, but it's been packed with plenty of new offerings.

If you're into new things, there's a new report detailing the only stock you need to cash in on a new technology revolution. The report is free, but it won't be around forever so check it out now.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1785375, ~/Articles/ArticleHandler.aspx, 10/28/2016 12:41:16 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,245.83 76.15 0.42%
S&P 500 2,139.50 6.46 0.30%
NASD 5,229.79 13.82 0.26%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 12:24 PM
BCOV $11.60 Down +0.00 +0.00%
Brightcove CAPS Rating: **
CZR $7.10 Down -0.05 -0.70%
Caesars Entertainm… CAPS Rating: *
GSEHQ $0.00 Down +0.00 +0.00%
GWAY.DL $0.00 Down +0.00 +0.00%
HMST $26.99 Up +0.24 +0.90%
HomeStreet CAPS Rating: ***